Towards new approaches to disorders of fear and anxiety

Curr Opin Neurobiol. 2013 Jun;23(3):346-52. doi: 10.1016/j.conb.2013.01.013. Epub 2013 Feb 9.

Abstract

Fear and anxiety are debilitating conditions that affect a significant number of individuals in their lifetimes. Understanding underlying mechanisms of these disorders affords us the possibility of therapeutic intervention. Such clarity in terms of mechanism and intervention can only come from an amalgamation of research from human to animal studies that attempt to mimic the human condition, both of which are discussed in this review. We begin by presenting an outline of our current understanding of the neurobiological basis of fear and anxiety. This outline spans various levels of organization that include the circuitry, molecular pathways, genetic and epigenetic components of fear and anxiety. Using these organizational levels as a scaffold, we then discuss strategies that are currently used to ameliorate these disorders, and forecast future interventions that hold therapeutic promise. Among these newer promising treatments, we include, optogenetic, pharmacological, and extinction-based approaches, as well as lifestyle modifications, with combinatorial treatment regimens of these holding the most promise.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Anxiety / genetics*
  • Anxiety / physiopathology*
  • Anxiety Disorders / genetics
  • Anxiety Disorders / physiopathology
  • Anxiety Disorders / therapy
  • Brain / physiopathology*
  • Epigenesis, Genetic
  • Fear / physiology*
  • Genetic Predisposition to Disease
  • Humans
  • Neurology / trends